Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study

BACKGROUND: Pirfenidone is an antifibrotic agent that is potentially effective for the treatment of idiopathic pulmonary fibrosis (IPF). However, no study has reported on its prophylactic value against chemotherapy‐associated acute IPF exacerbations when combined with chemotherapy for non‐small cell...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Yamamoto, Yuji, Yano, Yukihiro, Kuge, Tomoki, Okabe, Fukuko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2020
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606001/
https://ncbi.nlm.nih.gov/pubmed/32986306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13675
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items